HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study

Introduction: Affordable and sensitive screening methods for acute hepatitis C (HCV) are necessary to successfully intervene in the current HCV epidemic among HIV‐positive men having sex with men. HCV core antigen (Ag) testing has been proven effective in diagnosing chronic HCV‐infected patients at low costs. We studied the characteristics of HCV Ag testing in acute HCV‐infected HIV‐positive patients.

[1]  J. M. Freiman,et al.  Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection , 2016, Annals of Internal Medicine.

[2]  W. Bierman,et al.  Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients. , 2016, Journal of hepatology.

[3]  M. V. van Kasteren,et al.  Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  H. Hagan,et al.  Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men , 2015, AIDS.

[5]  P. Klenerman,et al.  Current knowledge and future perspectives on acute hepatitis C infection. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  S. Bruisten,et al.  Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV. , 2015, Journal of virological methods.

[7]  F. Cresswell,et al.  Hepatitis C core antigen testing: a reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Capobianchi,et al.  HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes , 2014, BMC Infectious Diseases.

[9]  H. Günthard,et al.  Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Joseph Eliahoo,et al.  Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men , 2010, Gut.

[11]  G. Gerken,et al.  Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification , 2010, Journal of Clinical Microbiology.

[12]  H. Saegusa,et al.  A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. , 2009, Journal of virological methods.

[13]  E. Thomson,et al.  Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV , 2009, AIDS.